CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 107 enrolled
Drug / intervention
Not specified
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03491228
NCT03491228N/ACompleted
CompareCT.gov

METRONIDAZOLE IV DRUG USE INVESTIGATION

Pfizer·observational·Posted Apr 9, 2018·Updated Dec 28, 2018

In Brief

An observational study for Anaerobic Infection and 2 related conditions. Completed, enrolled 107 participants.

Detailed Summary

Secondary Data Collection Study; safety and effectiveness of Anaemetro under Japanese medical practice

Study Details

Study Typeobservational
Allocation--
Masking--
Primary Purpose--
ConditionsAnaerobic Infection, Infectious Enterocolitis, Amebic Dysentery
Countries--
Collaborators--

Timeline

N/ACompletedFinished
20162017201820192020202120222023202420252026
First PostedApr 9, 2018
Enrollment StartJul 1, 2015
Primary CompletionAug 1, 2017
TodayJul 2, 2026
Enrollment to primary: 2.1 yearsPosted 8.2 years ago